Drug intelligence / Profile preview

AGLS

Development stage: Unknown
Lead developer: AHN-GOOK PHARMACEUTICAL
Administration: Subcutaneous

Overview

AGLS is an investigational pharmaceutical drug developed by Ahn-Gook Pharmaceuticals Co.,Ltd. It is currently undergoing a Phase III clinical trial to evaluate its efficacy and safety in patients with essential hypertension. Further details regarding its specific mechanism of action, canonical name, and other characteristics are not publicly available.

Beyond the preview

Go deeper on AGLS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AGLS.

Explore the full profile